2023 TOS Summit (夏3冬＿)

By /

07/15 (Sat) ⬅️ (第一場 New drug, Pan-cancer, GU)

  1. 09:10–09:15 年輕硏究者癌症硏究傑出論文奬頒獎 – 得獎人：楊文綺醫師/謝承恩醫師
  2. 09:15–09:30 年輕研究者癌症硏究傑出獎頒獎暨演講 – 得獎人：陳偉武醫師
  3. 09:30–10:15 Major Advances of 2023 ASCO Meeting: Experimental Therapeutics & New Drug Development (林家齊 教授 臺大醫院)
  4. 10:30–11:05 Major Advances in 2023 ASCO: New Drug Development in p53, DLL3 and HER2 pathways (官鋒澤醫師 嘉義長庚醫院)
  5. 11:05–11:40 NGS new updates and progress from ASCO 2023 (張家崙醫師 萬芳醫院)
  6. 11:40–12:15 A Deep Dive From ASCO 2023: Emerging genome-wide biomarkers and updated clinical data among multiple cancers (官鋒澤醫師 嘉義長庚醫院)
  7. 12:15–12:35 Ongoing considerations for COVID-19 prevention in cancer patients (蔡承宏醫師 臺大醫院)
  8. 13:00–13:45 Major Advances of 2023 ASCO Meeting: GU Cancers (蘇祐立醫師 高雄長庚醫院)
  9. 13:45–14:20 The latest update in immunotherapy for patients with renal cell carcinoma (黄文冠醫師 林口長庚醫院)
  10. 14:20–14:55 Evolving treatment landscape in metastatic prostate cancer (蘇柏榮醫師 林口長庚醫院)
  11. 15:05–15:40 Sequencing systemic therapies in advance/ metastatic UC: how do we decide? (葉士芃主任 中國附醫)
  12. 15:40–16:15 Set a Course for Longer Survival with Novel Nectin-4-Directed ADC in LA/mUC (張牧新醫師 臺北榮民總醫院)

07/16 (Sun) ⬅️ (第二場 Breast, GI)

  1. 09:10–09:15 年輕研究者癌症硏究傑出獎頒獎暨演講 – 得獎人：鍾為邦醫師
  2. 09:25–10:10 Major Advances of 2023 ASCO Meeting: Breast Cancer– 得獎人：劉峻宇醫師 臺北榮民總醫院
  3. 10:25–11:00 What can we expect more from CDK4/6i in HR+HER2-mBC treatment? (楊展庚醫師 林口長庚醫院)
  4. 11:00–11:35 What’s new in HR+/Her2- advanced breast cancer treatment? Perspective from clinical trials to real-world evidence (陳偉武醫師 臺大醫院)
  5. 11:35–12:10 Exploring the Efficacy and Safety of Ribociclib Combined with Endocrine Therapy in the Adjuvant Treatment of HR+/HER2- Early Breast Cancer: Insights from the NATALEE Phase Ill Study (鍾為邦醫師 成大醫院)
  6. 13:00–13:45 Major Advances of 2023 ASCO Meeting: GU Cancers (蘇祐立醫師 高雄長庚醫院)
  7. 13:45–14:20 The Latest advancement in the treatment of advanced and metastatic GC and BTC (姜乃榕醫師 臺北榮民總醫院)
  8. 14:20–14:55 Major advances of colorectal cancer in 2023 ASCO meeting (梁逸歆醫師 臺大醫院)
  9. 14:55–15:30 Comprehensive review of 3rd-4th line treatment for metastatic CRC (徐鴻智醫師 林口長庚醫院)
  10. 15:40–16:15 Immunotherapy in colorectal cancer: recent advances and future direction (謝孟哲醫師 義大醫院)
  11. 16:15–16:50 Advances of antibody-drug conjugates in CRC and Pan-Tumor (梁逸歆醫師 臺大醫院)
  12. 16:50–17:25 Precision Medicine in Gl Cancer Management: Where are We Now? (陳敬左醫師 新竹臺大醫院)

07/22 (Sat) ⬅️ (第三場 H&N, Solid tumor, Lung cancer)

  1. 09:10–09:50 Major Advances of 2023 ASCO Meeting: Head and Neck Cancer (高祥豐醫師 臺大醫院癌醫中心分院)
  2. 09:50–10:30 Major Advances of 2023 ASCO Meeting: solid tumor overview (郭宇如醫師 臺大醫院)
  3. 10:45–11:25 Major Advances of 2023 ASCO Meeting: Lung Cancer-1 (吳教恩醫師 林口長庚醫院)
  4. 11:25–12:00 Clinical update of Larotrectinib in NTRK fusion lung cancer at ASCO 2023(夏德椿主任 中國附醫)
  5. 12:00–12:35 Immunotherapy for NSCLC in 2023- from locally advanced to the metastatic stage (廖唯昱醫師 臺大醫院)
  6. 13:00–13:35 New era of RET fusion-positive NSCLC: optimizing treatment outcomes with precision medicine therapy (張境夫醫師 桃園長庚醫院)
  7. 13:35–14:10 Navigation First-Line Treatment Decisions to Optimize Outcomes for EGFRm+ NSCLC: From Clinical Evidence to Real World Excellence (黄彥翔醫師 臺中榮民總醫院)
  8. 14:10–14:45 Bridging the clinical & biomarker data in the management of ALK+ NSCLC (吳尚俊醫師 臺大醫院)
  9. 14:55–15:30 Optimal ALK+ NSCLC treatment strategy (官鋒澤醫師 嘉義長庚醫院)
  10. 15:30–16:10 Major Advances of 2023 ASCO Meeting: Lung Cancer-2 (邱昭華副院長 臺北癌症中心)
  11. 16:10–16:20 Panel Discussion & Closing (楊志新院長 臺大醫院癌醫中心分院)
Scroll to Top